hotspot -WSS

hotspot

author：hotspot 2025-10-02 23:47:11 - browse：231

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Group behind ProMed defends move to subscription

WSS

Amylyx ALS drug failure raises questions and concerns

The problem with charging patients to message their doctors

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Sen. Paul opposes bill to ban Chinese biotechs

Pharma showers House GOP doctor with campaign cash

explore

hotspot

entertainment

At least 13 dead in Texas as scorching temps continue

'Null' research findings aren't empty of meaning. Let's publish them

Virginia high school admissions case could be legal follow

The drug industry has found itself all alone in Washington

Cancer drug shortages should be causing more outrage

Group behind ProMed defends move to subscription

Tori Bowie and the unacceptable rates of Black maternal death

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Activists slam private health insurers over coverage restrictions

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Wikipedia

Physicians aren't 'burning out.' They're suffering from moral injury

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Study links childhood stress with decline in older age

Just how do doctors, lawmakers, and the public define abortion?

RSV shot was 90% effective at preventing hospitalizations in kids

hotspot

leisure time

knowledge

leisure time